13.03.2018

Mannheim: Die FDA nach dem MRA: Grundlagen und aktuelle Entwicklungen (QS 3)

In this conference, Dr. Hiltrud Horn will give detailed insight into the essentials about regulatory requirements in US and preparation of dossiers in US (IND, NDA, DMF). Furthermore Dr. Horn will present how to successfully prepare for meetings with Authorities and how to handle changes.

For more information please visit the following website:
https://www.gmp-navigator.com/daten/seminarpdf/QS3-Die-FDA-nach-dem-MRA.pdf


(Conference organized by Concept Heidelberg)

Back

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

Get all events



News

  • 19.12.2022
    EU Update regarding Deadlines of Nitrosamine Impurities
    More
  • 01.09.2022
    EU-GMP Annex 1 finally published
    More
  • 26.08.2022
    New Deadlines and Chances for Nitrosamines
    More
Get all news